-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
Ukraine's tuberculosis progress 'stopped in one day'
As Ukraine struggles to cope with the immediate casualties of Russia's invasion, there are fears the war will also ruin the country's progress in its fight against tuberculosis.
Ukraine has long struggled with tuberculosis, which was the world's biggest infectious killer before the emergence of Covid-19 and spreads in a similar manner.
Despite being diagnosable and normally easily treatable, the disease kills 1.5 million people a year globally and infects more than 10 million, according to the World Health Organization.
Ukraine records around 30,000 new cases annually and has one of the world's highest rates of drug-resistant tuberculosis, which represented 29 percent of the country's new tuberculosis patients in 2018, according to WHO figures.
But Ukraine has worked to address the problem, in recent years becoming the first country to trial a new pill against drug-resistant tuberculosis, which occurs when the two most powerful antibiotics cannot kill the TB bacteria.
"Before the war, Ukraine had achieved a lot," said Olya Klymenko, who recovered from tuberculosis in 2016 and went on to found an NGO, TB People Ukraine.
"But everything stopped in one day," she said. That day was February 24, when Russian troops invaded Ukraine.
"When the war is over we will start everything not even from scratch because of the damage which occurred to our medical care, to our medical infrastructure," she told a press conference ahead of World Tuberculosis Day on Thursday.
Askar Yedilbayev, the TB unit lead at WHO's European office, said Ukraine was "one of the pioneering countries in response" to the disease in the region and praised its "exemplary work".
He said that, before the war, regional warehouses had been well-stocked and patients had been provided with one-to-two months' supply of TB medication.
But with Russia's invasion, "Ukraine's public health services have been derailed," affecting tuberculosis diagnosis and treatment, he told journalists.
- 'Major health crisis' -
Michel Kazatchkine, former UN special envoy for HIV/AIDS in Eastern Europe and Central Asia, said the problem now is getting the medication to patients.
"There will be a major health crisis," he told AFP.
"Ukraine will be left with a totally collapsed health system... diseases such as TB and drug-resistant TB will really surge afterwards," Kazatchkine warned.
Kate White, Doctors Without Borders emergency programme manager in Geneva, said the "extreme burden" of the war has led to resources for TB and HIV patients being diverted to treat the wounded.
Yet another problem is how to continue treatment for those fleeing the violence.
"We've lost track of many of our patients, because they, like so many others in the country, have fled," White told AFP.
Yedilbayev said the WHO was supporting the neighbouring countries in providing healthcare to those fleeing the violence, highlighting that "every second, one Ukrainian child becomes a refugee".
- 'Catastrophic' setback -
The Ukraine crisis comes as the "Covid-19 pandemic has, in just two years, catastrophically set back global progress against TB by a decade," said Jose Luis Castro, president of global health organisation, Vital Strategies.
"Covid-19 halved TB case detection in the country in 2020, and the ongoing war could bring diagnosis and treatment to its knees," he said in a statement.
The WHO has warned that tuberculosis deaths worldwide increased in 2020 for the first time in more than a decade.
This week, the WHO called for vastly increased funding, after global spending on TB diagnostics, treatment and prevention in 2020 was less than half of the target of $13 billion annually by 2022.
Many have called for more efforts to develop a new vaccine against tuberculosis -- the current BCG vaccine is a century old and "completely inefficient for adults," said Lucica Ditiu, executive director of the Geneva-based Stop TB Foundation.
"For 100 years, we didn't manage to get a new vaccine. We saw that Covid was able to motivate the minds and money of people to get a new vaccine in 10 months," she said.
"That is nothing less than we should hope for tuberculosis."
R.Chavez--AT